शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
PARKHOSPSNSEPARK MEDI WORLD LIMITED· Healthcare ServicesHighNeutral
Announced Mon, 3 Aug, 2026 · 09:46 IST

Park Medi World Q1 FY27 results: Revenue up 19%, Net Profit up 35%

Profit growth above 25%EBITDA margin expansionResults View source PDFExplain this filing

PARKHOSPS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.4%Reaction day
₹293.05
prior close
₹296.75
announcement price
In-mkt
timing
Nifty Microcap 250market+1.3%-3.7% vs market
Hospital peers, median of 25sector+0.5%-2.9% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 2.9 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.2
15m
-0.4
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.4+1.3-3.7+0.5-2.9
Next day
-3.4+1.8-5.2+0.2-3.7
2d
-2.7+3.1-5.8-0.1-2.7
3d
-0.7+3.5-4.2+0.4-1.1
4d
-0.6+3.5-4.1+1.7-2.3
5d
-1.4+3.4-4.8+2.9-4.3
1w
-3.5+3.6-7.1-0.4-3.1
15d
-4.1+4.9-9.0-2.6-1.6
1m
-2.6+4.4-7.0-2.7+0.2
2m
-7.9+2.9-10.8-10.7+2.8
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Park Medi World reported Q1 FY27 unaudited results. Revenue rose 19% YoY to INR 4,757 mn. EBITDA grew 20% to INR 1,261 mn with margin at 26.5% (up 20 bps). Net Profit jumped 35% to INR 886 mn, margin expanded 220 bps to 18.6%. EPS stood at INR 2.05. The company plans to add 1,490 beds in calendar year 2026, about 46% capacity addition. Term debt is negligible at INR 256 mn with INR 2,998 mn in fixed deposits.

Likely market impact

Strong quarterly performance with double-digit growth across revenue, EBITDA and profit. Major bed expansion planned, funded with minimal debt. Positive outlook for shareholders.